Table 1. Dosimetric comparison between VMT-5B and VMAT-10B for the targets.
Parameters | VMAT-5B | VMAT-10B | P value |
---|---|---|---|
PTV | |||
V95% (%) | 99.59 ± 0.33 | 99.58 ± 0.34 | 0.799 |
D95% (Gy) | 49.9 ± 0.22 | 50.07 ± 0.10 | 0.074 |
D98% (Gy) | 49.0 ± 0.35 | 49.00 ± 0.32 | 0.445 |
Dmean (Gy) | 52.10 ± 0.28 | 52.13 ± 0.36 | 0.878 |
D2% (Gy) | 54.20 ± 0.43 | 53.78 ± 0.46 | <0.001 |
V110% (%) | 0.39 ± 0.59 | 0.06 ± 0.12 | 0.005 * |
HI | 0.10 ± 0.01 | 0.09 ± 0.01 | <0.001 |
CTV | |||
V95% (%) | 99.90 ± 0.04 | 99.98 ± 0.03 | 0.028 * |
D95% (Gy) | 50.70 ± 0.35 | 51.23 ± 0.35 | <0.001 |
D98% (Gy) | 50.30 ± 0.37 | 50.87 ± 0.35 | <0.001 |
Dmean (Gy) | 52.30 ± 0.31 | 52.43 ± 0.41 | 0.391 |
D2% (Gy) | 54.30 ± 0.45 | 53.80 ± 0.46 | <0.001 |
V110% (%) | 0.47 ± 0.66 | 0.04 ± 0.08 | 0.005 * |
HI | 0.08 ± 0.01 | 0.06 ± 0.01 | <0.001 |
The values in bold indicate significant differences.
*Significant differences with paired Wilcoxon signed-rank test.